Market size, share and growth analysis by type, treatment, route of administration and end users, across all major regions and key countries, with forecasts for 2024–2033. The competitive landscape profiles 20+ companies.
The global drug addiction treatment market was valued at USD 18.6 Bn in 2024 and is projected to reach USD 36.8 Bn by 2033, growing at a CAGR of 7.5%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Drug Addiction Treatment Market Overview
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
The CMI Team's most recent market research predicts that from 2024 to 2033, the global market for drug addiction treatment will grow at a 7.5% CAGR. In 2023, the market size is projected to reach a valuation of USD 18.6 Billion. By 2033, the valuation is anticipated to reach USD 36.8 Billion.
Patients receiving therapy for substance addiction are those who are unable to manage their cravings. Alcohol, nicotine, and prescription medications have a significant impact on this disorder. Drug addiction impacts not only brain functionality but also affect health and social function. It causes individuals to lose self-control, which then fuels more harmful habits.
When it comes to other medication classes, opioid medicines are less likely to cause addiction quickly and carry a higher risk. The drug addiction market share growth is attributed to several factors, such as the rising prevalence of substance use disorders, increasing awareness and acceptance, expansion of insurance coverage, advancements in treatment options, and rising government initiatives. However, the lack of awareness and high treatment costs restrict the expansion of the industry during the analysis period.
Drug Addiction Treatment Market: Growth Factors
Advancements in treatment propel the global drug addiction industry
The ongoing development of treatment approaches, such as medications and psychosocial interventions, has a positive impact on the market for drug addiction treatment. Buprenorphine, Narcone, and methadone are the common drugs used in medical-assisted therapies (MAT).
In the treatment of substance use disorders, MAT therapy is very beneficial. Behavioral therapies work better with digital and personalized treatment to improve patient recovery outcomes. These developments have led to an expansion of the drug addiction treatment market.
Increasing government support influences market revenue.
Drug addiction treatment programs are receiving proper support from government authorities across the globe as governments acknowledge addiction as a serious public health issue. Initiatives that lower drug misuse, raise public awareness and improve treatment accessibility.
Through this treatment is more affordable and accessible by a combination of public-private partnerships, regulatory reforms, and financial grants. This kind of public assistance not only makes treatment services more accessible but also fosters ongoing innovation in therapeutic modalities and drives market expansion.
Drug Addiction Treatment Market: Recent Development
The drug addiction treatment industry adopted several strategies, which include product approvals, acquisitions, expansion and others. Some of the company strategies include:
These approvals increased the market significance of the company and capitalize its revenue through its innovative offering.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Drug Addiction Treatment Market | Animal Genetics Market | Smart Orthopedic Implants Market |
| CAGR 7.5% (Approx) | CAGR 5.89% (Approx) | CAGR 5.10% (Approx) |
| USD 36.8 Billion by 2033 | USD 10.88 Billion by 2033 | USD 34.89 Billion by 2033 |
Drug Addiction Treatment Market - Challenge
Reluctance to substance use disorder limits the market
Patients with substance use disorder have a strong resistance, which is one of the primary issues limiting the market's revenue. As per the data published by the National Survey on Drug Use and Health (NSDUH), over 14% of adults have substance use disorder (12 years or older).
In addition, the evidence that people are reluctant to seek medical assistance due to stigma and reluctance to the impacts of substance use comes from the gradual increase in the number of patients seeking treatment for mental health and other issues.
Drug Addiction Treatment Market: Segment Analysis
By Type:
The opioid addiction type garnered the strongest growth in 2023. The expansion is owing to the several programs by public and private players. Moreover, the growing product approvals favor segment growth.
Besides, the barbiturate addiction segment is expanding at a faster rate during the projected period because it is a life-threatening disorder that needs continuous intervention and treatment.
By Treatment:
The medication segment held the largest revenue share in 2023. The market for opioid addiction treatment has grown overall as a result of the surge in naloxone demand brought on by an increase in opioid overdose rates.
Besides, the therapy segment is expected to grow rapidly over the analysis period. The market is expanding due to the growing demand for CBT, which has increased the need for qualified therapists and digital therapy platforms that provide CBT-based programs.
By Route of Administration:
The oral route of administration is expected to capture a prominent market share during the forecast period. The need for methadone is still high due to the growing opioid crisis, especially in North America, which is driving revenue in the oral drug addiction treatment market.
Nevertheless, the parenteral segment is growing rapidly over the analysis period. The demand for Vivitrol has increased due to the growing preference for long-acting injectables over oral drugs taken daily, especially in settings for inpatient and outpatient addiction treatment.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 18.6 Billion |
| Projected Market Size in 2033 | USD 36.8 Billion |
| Market Size in 2023 | USD 17.9 Billion |
| CAGR Growth Rate | 7.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Treatment, Route of Administration, End Users, Distribution Channel and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your research requirements. |
Drug Addiction Treatment Market - Regional Analysis
North America is projected to lead the market growth during the analysis period. The regional market is anticipated to be driven by the expanding number of people who are susceptible to addiction, well-organized reimbursement systems, the legalization of marijuana in certain states, and improved healthcare sectors.
In the United States, around 17% of people binge drink, and 6% of people are exposed to heavy drinking, according to the CDC. Moreover, nicotine addiction is most frequent in the U.S. with almost 40 million people addicted to tobacco smoking. Therefore, a sizable market for addiction treatment in North America has opened up.
However, the Asia Pacific is growing at a significant pace in the global drug addiction treatment industry. This can be attributed to the geographic spread of major actors in Asian nations, as well as the advancement of healthcare infrastructure and government programs that encourage the use of treatment for drug, alcohol, and nicotine addiction.
Competitive Landscape: Drug Addiction Treatment Market
The drug addiction treatment market is highly competitive, with a large number of manufacturers operating globally. Some of the key players in the market include:
These companies adopted strategies such as product launches, product approvals, merger & acquisition, and collaboration.
Regional Coverage:
North America
Europe
Asia Pacific
The Middle East & Africa
Latin America
Updated: January 2026 · Formats: PDF, Excel, PPT
The key factors driving the Market are Advancements in treatment propel the global drug addiction industry, Increasing government support influences market revenue.
The "Opioid Addiction" category dominated the market in 2023.
The key players in the market are Medtronic, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Abbott, BD, Johnson & Johnson Services Inc., GSK Plc, Bayer AG, Stryker Corporation, Zimmer Biomet, Homology Medicines Inc, Novartis AG, AVROBIO Inc, JCR Pharmaceuticals Co. Ltd., Sangamo Therapeutics, Pfizer Inc., REGENXBIO Inc, CANbridge Life Sciences Ltd., Denali Therapeutics, Jasper Therapeutics Inc., Others.
"North America" had the largest share in the Global Drug Addiction Treatment Market.
The global market is projected to grow at a CAGR of 7.5% during the forecast period, 2024-2033.
The Global Drug Addiction Treatment Market size was valued at USD 18.6 Billion in 2024.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 10 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleThe Global Drug Addiction Treatment Market is segmented as follows:
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample